Skip to main navigation Skip to search Skip to main content

Obesity is associated with adverse outcomes in primary immune thrombocytopenia - a retrospective single-center study

Research output: Contribution to journal › Article › peer-review

Abstract

The pathophysiology of immune thrombocytopenia (ITP) involves immune-mediated platelet destruction. The presence of adipose tissue in obese individuals creates an inflammatory environment that could potentially impact the clinical course and outcomes of ITP. However the relationship between obesity and ITP outcomes has not been well described. We evaluated ITP outcomes in 275 patients diagnosed with primary ITP from 2012 to 2022. Patients were categorized into four groups based on their body mass index (BMI) at diagnosis. Female gender was associated with a lower platelet count at the time of diagnosis at any BMI. Patients with high BMI had lower platelet counts at diagnosis and at platelet nadir (p < 0.001), an increased likelihood of requiring therapy (p < 0.001) and requiring multiple lines of therapy (p = 0.032). Non-obese patients who required corticosteroid treatment experienced a longer remission duration compared to obese patients (p = 0.009) and were less likely to be steroid-dependent (p = 0.048). Our findings suggest that obesity may be a significant risk factor for developing ITP and for ITP prognosis. Future studies are needed to evaluate the role of weight loss intervention in improving ITP outcomes.

Original languageEnglish (US)
Pages (from-to)3453-3461
Number of pages9
JournalAnnals of Hematology
Volume103
Issue number9
DOIs
StatePublished - Sep 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • ITP
  • Obesity
  • Outcomes
  • Prognosis
  • Thrombocytopenia

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Obesity is associated with adverse outcomes in primary immune thrombocytopenia - a retrospective single-center study'. Together they form a unique fingerprint.

Cite this